New oral anticoagulants show promise.
Tracy
T
Hampton
D000925:Anticoagulants / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D065427:Factor Xa Inhibitors; D000077425:Fondaparinux; D005998:Glycine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D011134:Polysaccharides / Q000627:therapeutic use; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use*; D013923:Thromboembolism / Q000517:prevention & control*
D000925:Anticoagulants; D065427:Factor Xa Inhibitors; C507963:LY517717; D009025:Morpholines; D010879:Piperazines; D011134:Polysaccharides; D013876:Thiophenes; D000069552:Rivaroxaban; D000077425:Fondaparinux; D005998:Glycine